secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2024-09-09T23:59:59+00:00
Accession:  0001104659-24-098225
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics issues 27,316 common shares upon conversion of Series C and D preferred stock
--------------------------------------------------------------------------------

- 4,138 Series C shares converted into 1,086 common shares at $30.50 per share.
- 100,000 Series D shares converted into 26,230 common shares at $30.50 per share.
- Total 27,316 common shares issued; no Series C or D preferred shares remain outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465924098225/0001104659-24-098225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465924098225/tm2423567d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-098225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer